Warning: getimagesize(https://magazine.pharmamkt.net/wp-content/uploads/2020/09/logo-group.jpg): failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /home/luciamun/public_html/magazine/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 792

The largest community of pharma leaders

The Power of Habit – Creating Positive Feedback Loops in Healthcare

Did you know that almost half of all decisions are based on habits? However, that does not mean that we cannot change our habits (and thereby make better decisions)!

Focusing on habits in healthcare, there are a lot of questions around this topic. For example, how are habits formed? What factors influence the sustainability of habits? Is there a way to help modify HCP habits in a positive way?

In our next webinar, The Power of Habit – Creating Positive Feedback Loops in Healthcare (September 3rd, 2019 | 10am EST, 3pm CET), Natalie Yeadon, Co-owner and Managing Director of Impetus Digital, will answer these questions and many more.In this 30-minute webinar, you will learn:

  • How to leverage prompts to trigger positive HCP behaviours
  • Different ways to make HCP behaviour changes achievable
  • The principles behind HCP behaviour motivation
  • How to leverage virtual platforms to inspire habits

Spots are limited; register today so that you don’t miss out! http://bit.ly/2zkQG1EIf you can’t join us live, don’t worry. We’ll send a link to a recording to all those who sign up.

About Natalie Yendon: Natalie worked in the pharmaceutical industry for over 18 years in a variety of sales, marketing, and early brand commercialization management roles. Currently, she is the Co-owner and Managing Director of Impetus Digital where she dedicates her time to helping life science companies create sustained and authentic relationships with their key customers through Impetus’ cutting-edge online collaboration platform, the Impetus InSite Platform®.
0FansLike
0FollowersFollow
0FollowersFollow
0FollowersFollow

Recent Articles

Asana BioSciences to Present Positive Results from Phase 2b Study of Oral JAK/SYK Inhibitor Gusacitinib in Patients with Chronic Hand Eczema in the Late-Breaking...

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences’ Oral Gusacitinib (ASN002) demonstrates rapid and significant...

Aptinyx Announces Proposed Public Offering of Common Stock

EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing...

Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging...

AppliedVR Receives FDA Breakthrough Device Designation to Treat Pain with Digital Therapeutic

LOS ANGELES--(BUSINESS WIRE)-- #chronicpain--AppliedVR, a pioneer advancing the next generation of...

After Meeting with FDA, Guided Therapeutics to Start Study in Support of its Application for FDA Approval

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- #FDA--After Meeting with FDA, Guided Therapeutics to...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.